Celyad focuses on translating promising research into transformative treatments aimed at reversing the outcome of severe diseases. Celyad identifies and further advances therapeutic solutions that have the potential to change the lives of thousands of patients worldwide.
Our scientific approach is inspired by natural mechanisms that are used by the body to fight disease. We put all our efforts into developing and delivering best-in-class therapies that will re-engage these natural mechanisms in patients. We know that every second counts for patients, this is what drives us in our work every day.

Type
Public
HQ
Mont-Saint-Guibert, BE
Founded
2007
Size (employees)
82 (est)
Celyad was founded in 2007 and is headquartered in Mont-Saint-Guibert, BE

Celyad Office Locations

Celyad has offices in Mont-Saint-Guibert, Boston
Mont-Saint-Guibert, BE
Boston, US

Celyad Metrics

Celyad Summary

Market capitalization

€190.4 b

Closing share price

€20.2
Celyad's current market capitalization is €190.4 b.

Celyad Market Value History

Celyad Online Presence

Celyad Company Life

You may also be interested in